The cynomolgus monkey (Macaca fascicularis) is the best animal model for the study of steroid glucuronidation

被引:36
作者
Barbier, O [1 ]
Bélanger, A [1 ]
机构
[1] Univ Laval, CHUL, Med Ctr, Oncol & Mol Endocrinol Res Ctr, Ste Foy, PQ G1V 4G2, Canada
关键词
steroidogenesis; cynomolgus monkey; metabolites;
D O I
10.1016/S0960-0760(03)00235-8
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
intense research efforts performed during the past decade clearly established the major role of glucuronidation and uridine-diphosphoglucuronosyltransferase (UGT) enzymes for steroid metabolism in humans. However, a clear understanding of the physiological importance of this metabolic process requires in vivo studies. Numerous evidences ascertain that simians are the most appropriate animal models for such studies. Indeed human and monkey have a similar pattern of steroidogenesis, unlike common laboratory mammals such as rat or mouse. Furthermore, human and monkey are unique in having high levels of circulating androsterone glucuronide and androstane-3alpha-diol glucuronide (3alpha-Diol-G). In addition, characterization of eight monkey UGT proteins demonstrated the similarity of their conjugation activity toward steroid hormones. Like human ones, monkey enzymes are expressed in steroid target tissues, where they preferentially glucuronidate androgen and estrogen metabolites. In monkey tissues, immunohistochemical studies demonstrated that UGT2B proteins are expressed in a cell-type specific manner in ovary and kidney, where they control androgens and aldosterone inactivation. These results identify the cynomolgus monkey as an appropriate animal model for the determination of cellular localization of UGT enzymes in steroid target tissues and for the identification of endogenous or exogenous stimuli affecting steroid glucuronidation. (C) 2003 Published by Elsevier Ltd.
引用
收藏
页码:235 / 245
页数:11
相关论文
共 73 条
[51]   Complexities of glucuronidation affecting in vitro-in vivo extrapolation [J].
Lin, JH ;
Wong, BK .
CURRENT DRUG METABOLISM, 2002, 3 (06) :623-646
[52]  
Lohr JW, 1998, PHARMACOL REV, V50, P107
[53]   THE EFFECT OF N-LINKED GLYCOSYLATION ON THE SUBSTRATE PREFERENCES OF UDP GLUCURONOSYLTRANSFERASES [J].
MACKENZIE, PI .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1990, 166 (03) :1293-1299
[54]   The UDP glycosyltransferase gene superfamily: Recommended nomenclature update based on evolutionary divergence [J].
Mackenzie, PI ;
Owens, IS ;
Burchell, B ;
Bock, KW ;
Bairoch, A ;
Belanger, A ;
FournelGigleux, S ;
Green, M ;
Hum, DW ;
Iyanagi, T ;
Lancet, D ;
Louisot, P ;
Magdalou, J ;
Chowdhury, JR ;
Ritter, JK ;
Schachter, H ;
Tephly, TR ;
Tipton, KF ;
Nebert, DW .
PHARMACOGENETICS, 1997, 7 (04) :255-269
[55]   Structure of the human UGT2B4 gene encoding a bile acid UDP-glucuronosyltransferase [J].
Monaghan, G ;
Burchell, B ;
Boxer, M .
MAMMALIAN GENOME, 1997, 8 (09) :692-694
[56]   Effect of dioxin on ovarian function in the cynomolgus macaque (M-fascicularis) [J].
Morán, FM ;
Tarara, R ;
Chen, J ;
Santos, S ;
Cheney, A ;
Overstreet, JW ;
Lasley, BL .
REPRODUCTIVE TOXICOLOGY, 2001, 15 (04) :377-383
[57]   GENE STRUCTURE AT THE HUMAN UGT1 LOCUS CREATES DIVERSITY IN ISOZYME STRUCTURE, SUBSTRATE-SPECIFICITY, AND REGULATION [J].
OWENS, IS ;
RITTER, JK .
PROGRESS IN NUCLEIC ACID RESEARCH AND MOLECULAR BIOLOGY, VOL 51, 1995, 51 :305-338
[58]   The novel UGT1 gene complex links bilirubin, xenobiotics, and therapeutic drug metabolism by encoding UDP-glucuronosyltransferase isozymes with a common carboxyl terminus [J].
Owens, IS ;
Ritter, JK ;
Yeatman, MT ;
Chen, F .
JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1996, 24 (05) :491-508
[59]   THE NOVEL BILIRUBIN PHENOL UDP-GLUCURONOSYLTRANSFERASE UGT1 GENE LOCUS - IMPLICATIONS FOR MULTIPLE NONHEMOLYTIC FAMILIAL HYPERBILIRUBINEMIA PHENOTYPES [J].
OWENS, IS ;
RITTER, JK .
PHARMACOGENETICS, 1992, 2 (03) :93-108
[60]  
PILLOT T, 1993, J BIOL CHEM, V268, P25636